The Global Female SUI Devices Market is growing due to an aging female population, rising obesity rates, and a shift towards minimally invasive treatments. Key trends include the adoption of smart ...

Metastatic urothelial carcinoma has a poor prognosis: ~50% of muscle-invasive bladder cancer progresses to metastasis, and ...

The Company also announced that Frank Fischer, founder and chairman of the board of Neuropace and medtech serial entrepreneur, recently joined the Juniper Board of Directors.

West Tennessee Healthcare is pleased to announce a new treatment option for people living with urge urinary incontinence (UUI ...

Stress urinary incontinence affects up to one in three women worldwide, but the most commonly used treatment has led to ...

Valencia’s eCoin implantable tibial nerve stimulation (ITNS) system for urge urinary incontinence (UUI) treatment gained FDA ...

The deal would set up Boston Scientific to compete directly with Medtronic in the market for neuromodulation devices that ...

Boston Scientific (NYSE:BSX) announced today that it entered into an agreement to acquire Valencia Technologies for an undisclosed amount.

The US Food and Drug Administration (FDA) has granted 510 (k) clearance for BlueWind Medical, Ltd.’s enhanced Revi® implantable tibial neuromodulator for treatment of urgency urinary incontinence (UUI ...

For most people, the loss of a sense such as sight is devastating, not only for intensifying vulnerability, but for undermining quality of life. While prostheses can be functionally useful, they can’t ...

When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. A new brain-machine interface (BMI) uses light to "speak" to the brain, mouse experiments show.

St. Bernards Healthcare has implanted Arkansas’s first Altaviva™ tibial nerve device, offering a minimally invasive, anesthesia-free solution for overactive bladder and urge urinary incontinence.